75 related articles for article (PubMed ID: 25955689)
1. Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface.
Tang M; Yin G; Wang F; Liu H; Zhou S; Ni J; Chen C; Zhou Y; Zhao Y
Oncol Rep; 2015 Jul; 34(1):350-8. PubMed ID: 25955689
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
[TBL] [Abstract][Full Text] [Related]
3. Pro-MMP-9 upregulation in HT1080 cells expressing CD9 is regulated by epidermal growth factor receptor.
Herr MJ; Mabry SE; Jameson JF; Jennings LK
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):99-104. PubMed ID: 24246676
[TBL] [Abstract][Full Text] [Related]
4. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.
Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N
J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373
[TBL] [Abstract][Full Text] [Related]
5. CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling.
Wang GP; Han XF
Mol Med Rep; 2015 Jul; 12(1):1381-6. PubMed ID: 25760022
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells.
Vogelmann R; Kreuser ED; Adler G; Lutz MP
Int J Cancer; 1999 Mar; 80(5):791-5. PubMed ID: 10048983
[TBL] [Abstract][Full Text] [Related]
7. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
[TBL] [Abstract][Full Text] [Related]
9. Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation.
Stock AM; Hahn SA; Troost G; Niggemann B; Zänker KS; Entschladen F
Exp Cell Res; 2014 Aug; 326(2):307-14. PubMed ID: 24810090
[TBL] [Abstract][Full Text] [Related]
10. Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells.
Belo AI; van der Sar AM; Tefsen B; van Die I
PLoS One; 2013; 8(6):e65957. PubMed ID: 23824659
[TBL] [Abstract][Full Text] [Related]
11. Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis.
Nie F; Yang J; Wen S; An YL; Ding J; Ju SH; Zhao Z; Chen HJ; Peng XG; Wong ST; Zhao H; Teng GJ
Cancer; 2012 Nov; 118(21):5198-209. PubMed ID: 22510844
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.
Merlin J; Stechly L; de Beaucé S; Monté D; Leteurtre E; van Seuningen I; Huet G; Pigny P
Oncogene; 2011 Jun; 30(22):2514-25. PubMed ID: 21258405
[TBL] [Abstract][Full Text] [Related]
13. EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo.
Zhou C; Zhu L; Ji J; Ding F; Wang C; Cai Q; Yu Y; Zhu Z; Zhang J
Curr Cancer Drug Targets; 2017; 17(1):89-97. PubMed ID: 27739365
[TBL] [Abstract][Full Text] [Related]
14. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
15. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
Ozaki N; Ohmuraya M; Hirota M; Ida S; Wang J; Takamori H; Higashiyama S; Baba H; Yamamura K
Mol Cancer Res; 2009 Sep; 7(9):1572-81. PubMed ID: 19737965
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
18. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells.
Takai E; Tan X; Tamori Y; Hirota M; Egami H; Ogawa M
Int J Oncol; 2005 Sep; 27(3):645-51. PubMed ID: 16077912
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of EGFR and Hedgehog signaling pathway inhibition on the proliferation and apoptosis of pancreatic cancer cells.
Qin CF; Hao K; Tian XD; Xie XH; Yang YM
Oncol Rep; 2012 Aug; 28(2):519-26. PubMed ID: 22581058
[TBL] [Abstract][Full Text] [Related]
20. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]